A month of nightly zopiclone treatment does not worsen obstructive sleep apnoea (OSA) severity or symptoms in people with low to moderate arousal thresholds, according to Australian research. While hypnotics are typically contraindicated in OSA, the study extends the safety evidence for the sleeping tablets in this population beyond single-night studies. The randomised controlled trial ...
Already a member?
Enter your email to keep reading.